Inhibitors of cyclooxygenase-2 (COX-2) suppressed the proliferation and differentiation of human leukaemia cell lines

被引:62
|
作者
Nakanishi, Y [1 ]
Kamijo, R [1 ]
Takizawa, K [1 ]
Hatori, M [1 ]
Nagumo, M [1 ]
机构
[1] Showa Univ, Sch Dent, Dept Oral & Maxillofacial Surg 2, Ota Ku, Tokyo 1458515, Japan
关键词
U-937; ML-1; COX-2; inhibitor; NS-398; nabumetone; proliferation; differentiation; G0/G1; arrest;
D O I
10.1016/S0959-8049(01)00160-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Prostaglandins (PG) are known to play important roles in the proliferation and differentiation of leukaemia cells. The effect of the inhibitors of cyclooxygenase-2 (COX-2), a rate-limiting enzyme for the synthesis of PG, on the proliferation and differentiation of leukaemia cell lines was investigated. COX-2 inhibitors, NS-398 and nabumetone, suppressed the proliferation of U-937 and ML-1 cells by inducing a G0/G1 cell-cycle arrest. Cell-cycle arrest induced by these COX-2 inhibitors was not associated with an upregulation of the cyclin-dependent kinase inhibitors. COX-2 inhibitors also inhibited the differentiation of these cells induced by interferon-gamma (IFN-gamma), tumour necrosis factor-alpha (TNF-alpha) and retinoic acid (RA). Treatment with NS-398 did not suppress the levels of PGs produced by these cells. Although COX-2 antisense oligonucleotide showed a similar inhibitory effect on these cells, its inhibitory effect was smaller than that of NS-398, These results suggest that COX-2 inhibitors may suppress the proliferation and differentiation of leukaemia cells both via COX-2-dependent and -independent pathways. (C) 2001 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:1570 / 1578
页数:9
相关论文
共 50 条
  • [11] Cyclooxygenase-2 (COX-2) in carcinogenesis and selective cox-2 inhibitors for chemoprevention in gastrointestinal cancers
    Fujimura T.
    Ohta T.
    Oyama K.
    Miyashita T.
    Miwa K.
    Journal of Gastrointestinal Cancer, 2007, 38 (2-4) : 78 - 82
  • [12] Reduction in the risk of human breast cancer by selective cyclooxygenase-2 (COX-2) inhibitors
    Harris, RE
    Beebe-Donk, J
    Alshafie, GA
    BMC CANCER, 2006, 6 (1)
  • [13] Reduction in the risk of human breast cancer by selective cyclooxygenase-2 (COX-2) inhibitors
    Randall E Harris
    Joanne Beebe-Donk
    Galal A Alshafie
    BMC Cancer, 6
  • [14] Expression of cyclooxygenase-2 (COX-2) in human renal cell carcinoma (RCCa)
    McLaughlin, S
    Wallen, E
    Funkhouser, WK
    Pruthi, RS
    JOURNAL OF UROLOGY, 2004, 171 (04): : 266 - 267
  • [15] Selective cyclooxygenase-2 (COX-2) inhibitors and breast cancer risk
    Ashok, Varun
    Dash, Chiranjeev
    Rohan, Thomas E.
    Sprafka, J. Michael
    Terry, Paul D.
    BREAST, 2011, 20 (01): : 66 - 70
  • [16] 4,5-Diaryloxazole inhibitors of cyclooxygenase-2 (COX-2)
    Talley, JJ
    Bertenshaw, SR
    Brown, DL
    Carter, JS
    Graneto, MJ
    Koboldt, CM
    Masferrer, JL
    Norman, BH
    Rogier, DJ
    Zweifel, BS
    Seibert, K
    MEDICINAL RESEARCH REVIEWS, 1999, 19 (03) : 199 - 208
  • [17] Comparative QSAR analyses of cyclooxygenase-2 (COX-2) inhibitors.
    Garg, R
    Kurup, A
    Mekapati, SB
    Hansch, C
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 221 : U436 - U436
  • [19] Cyclooxygenase-2 (COX-2) is directly involved but not decisive in proliferation of human hepatocellular carcinoma cells
    Joong-Won Park
    Jung Eun Park
    Jung Ahn Lee
    Chang-Woo Lee
    Chang-Min Kim
    Journal of Cancer Research and Clinical Oncology, 2006, 132 : 184 - 192
  • [20] Inhibition of uveal melanoma cell proliferation by nepafenac, a selective cyclooxygenase-2 (COX-2) inhibitor
    Marshall, JCA
    Caissie, AL
    Saraiva, V
    Callejo, SA
    Filho, JPS
    Burnier, MN
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2004, 45 : U515 - U515